Physician profile
Michael Hoffman
NPI 1902907942
$1,644.09
in general payments reported to CMS, 2019-2025
26 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $143 · 2021: $21.25 · 2022: $96.26 · 2023: $316 · 2024: $156 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.91 |
| Education | $282.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $243.45 | 2019-2020 | |
| Coloplast Corp | $229.54 | 2019-2025 | Speedicath |
| Teva Pharmaceuticals USA, INC. | $182.94 | 2023 | |
| Sumitomo Pharma America, INC. | $167.17 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $114.95 | 2019-2025 | Erleada |
| Abbvie INC. | $85.81 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $82.23 | 2019-2022 | |
| Pfizer INC. | $72.10 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $70.29 | 2025 | |
| Tolmar, INC. | $52.03 | 2023-2024 | |
| Calyxo, INC. | $39.19 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $31.58 | 2020 | |
| Myriad Genetic Laboratories, INC. | $27.01 | 2023 | Prolaris |
| Laborie Medical Technologies Corp. | $26.01 | 2023 | |
| Blue Earth Diagnostics | $25.74 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $23.69 | 2019 | |
| Accord Healthcare, INC. | $23.19 | 2025 | |
| Rochester Medical Corporation | $22.18 | 2020 | |
| Olympus America INC. | $20.18 | 2022 | |
| Boston Scientific Corporation | $18.79 | 2019 | |
| Cook Medical LLC | $17.44 | 2024 | Cook |
| Urogen Pharma, INC. | $16.08 | 2025 | |
| Ferring Pharmaceuticals INC. | $15.25 | 2019 | |
| Allergan, INC. | $14.08 | 2019 | |
| Urovant Sciences INC | $12.13 | 2022 | |
| Neotract INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.